1.Guidelines for the management of hypertension.
Korean Journal of Medicine 1999;57(6):1067-1069
No abstract available.
Hypertension*
2.Management of Hypertension: New guideline and selection of antigypertensive drugs.
Korean Journal of Medicine 1999;57(4):817-822
No abstract available.
Hypertension*
3.Medical management of hypertension.
Korean Journal of Medicine 2002;63(1):105-111
No abstract available.
Hypertension*
4.The choice of drug and laboratory tests in hypertension.
Jae Heon KANG ; Sun Mi YOO ; Hyun Joo OH ; Ok Hee CHUN ; Tae Woo YOO ; Bong Yul HUH ; Chang Yup KIM
Journal of the Korean Academy of Family Medicine 1992;13(5):402-408
No abstract available.
Hypertension*
5.A New Guidelines for Hypertension JNC-6.
Journal of the Korean Medical Association 1998;41(4):400-412
No abstract available.
Hypertension*
6.Cellular and Molecular Pathophysiology of Idiopathic Pulmonary Arterial Hypertension.
Tuberculosis and Respiratory Diseases 2007;63(6):475-479
No abstract available.
Hypertension*
7.Ocular Diseases and Hypertension.
Korean Journal of Medicine 2012;83(5):591-595
No abstract available.
Hypertension
8.Pediatric Hypertension.
Young Seo PARK ; Jin Young JEONG
Korean Journal of Pediatrics 2004;47(Suppl 4):S908-S911
No abstract available.
Hypertension*
9.Property of Drugs in Hypertension.
Journal of the Korean Academy of Family Medicine 1998;19(3):234-246
No abstract available.
Hypertension*
10.Method validation of a high resolution melting analysis of a candidate genetic marker of hypertension
Mark Pretzel Zumaraga ; Marietta Rodriguez ; Vanessa Joy Timoteo ; Celeste Tanchoco
Journal of the ASEAN Federation of Endocrine Societies 2015;30(1):18-21
Objectives:
The study aimed to validate a high resolution melting (HRM) – polymerase chain reaction (PCR) based method for analysis of ATP2B1 rs2681472, a candidate genetic marker for hypertension. Specifically, the study aimed to establish method accuracy, inter- and intra-day precision, instrument detection limits (IDL) and linearity.
Methodology:
DNA samples from whole blood of selected respondents of the 2008 National Nutrition Survey (NNS) were analyzed for ATP2B1 rs2681472, following the HRM-PCR method. Analytical validation parameters such as method accuracy, inter- and intra-day precision, IDL and assay linearity were evaluated.
Results:
The data obtained using HRM conformed to data obtained from the current gold standard, which is direct DNA sequence analysis. Precision of the method is shown in the low intra-day and inter-day coefficients of variation of 0.11% and 0.14% respectively. The IDL was found at 1x10-2 ng DNA. Correlation coefficient using the method has met the acceptance criteria for linearity that is equal to 0.98.
Conclusion
HRM-PCR was successfully applied for analysis of ATP2B1 rs2681472. HRM is a highly commendable tool that can identify existence of polymorphisms in a genome which may be related to or which may cause hypertension. The method was found to be accurate and precise.
Hypertension
Result Analysis
Print
Save
E-mail